Significance Control of the COVID-19 pandemic has been impeded by the slow global uptake of targeted vaccines, emergence of more transmissible variants, and resistance to continuation of nonpharmaceutical interventions. Commonly used vaccines can have nonspecific immune effects, and several have been shown to have beneficial heterologous effects against SARS-CoV-2 infection. However, there is no science-based guidance on effective implementation of such heterologous vaccine interventions (HVIs) to counter the current or future pandemics. We modeled the effect of different HVI strategies on the winter 2020 COVID-19 wave in the United States, finding that targeting both elderly and nonelderly populations and intervening during pandemic growth phases (i.e., effective reproduction number > 1) led to the greatest reduction in morbidity and mortality. COVID-19 remains a stark health threat worldwide, in part because of minimal levels of targeted vaccination outside high-income countries and highly transmissible variants causing infection in vaccinated individuals. Decades of theoretical and experimental data suggest that nonspecific effects of non–COVID-19 vaccines may help bolster population immunological resilience to new pathogens. These routine vaccinations can stimulate heterologous cross-protective effects, which modulate nontargeted infections. For example, immunization with Bacillus Calmette–Guérin, inactivated influenza vaccine, oral polio vaccine, and other vaccines have been associated with some protection from SARS-CoV-2 infection and amelioration of COVID-19 disease. If heterologous vaccine interventions (HVIs) are to be seriously considered by policy makers as bridging or boosting interventions in pandemic settings to augment nonpharmaceutical interventions and specific vaccination efforts, evidence is needed to determine their optimal implementation. Using the COVID-19 International Modeling Consortium mathematical model, we show that logistically realistic HVIs with low (5 to 15%) effectiveness could have reduced COVID-19 cases, hospitalization, and mortality in the United States fall/winter 2020 wave. Similar to other mass drug administration campaigns (e.g., for malaria), HVI impact is highly dependent on both age targeting and intervention timing in relation to incidence, with maximal benefit accruing from implementation across the widest age cohort when the pandemic reproduction number is >1.0. Optimal HVI logistics therefore differ from optimal rollout parameters for specific COVID-19 immunizations. These results may be generalizable beyond COVID-19 and the US to indicate how even minimally effective heterologous immunization campaigns could reduce the burden of future viral pandemics.
【저자키워드】 COVID-19, vaccination, trained immunity, BCG, infectious disease modeling, 【초록키워드】 Resilience, Vaccine, pandemic, Mortality, Hospitalization, Vaccines, Influenza, SARS-COV-2 infection, COVID-19 pandemic, Infection, Nonpharmaceutical interventions, Intervention, immunization, variants, immune, Population, COVID-19 disease, malaria, Cohort, Health, infections, Viral, mathematical model, implementation, modeling, morbidity, influenza vaccine, Reproduction number, Effectiveness, Control, Pandemics, polio, age, Pathogens, morbidity and mortality, United States, incidence, Polio vaccine, Guidance, Heterologous, inactivated, Evidence, nonpharmaceutical intervention, heterologous vaccine, COVID-19 cases, growth, help, Drug administration, vaccinated individuals, Bacillus, parameter, transmissible variants, Effect, The United States, Effects, country, immunological, effective, benefit, shown, example, the United State, reduced, determine, modulate, dependent on, reduce, cross-protective, reduction in, stimulate, mathematical, nonspecific, Significance, transmissible variant, 【제목키워드】 pandemic, Intervention, modeling, reduce,